Domperidone vs Metoclopramide: Comparative Evaluation of Efficacy in Treating Diabetic Gastroparesis
Domperidone vs Metoclopramide: Efficacy in Treating Diabetic Gastroparesis
DOI:
https://doi.org/10.54393/pjhs.v7i1.3096Keywords:
Domperidone, Metoclopramide, Gastric Emptying, Diabetic GastroparesisAbstract
Gastroparesis represents a diabetes-related condition that causes diabetic patients to experience nausea, vomiting, and bloating. Objectives: To evaluate the effectiveness of Domperidone and Metoclopramide for gastric emptying improvement and gastrointestinal symptom reduction in patients with diabetic gastroparesis. Methods: A total of participants were n=76. Data collection occurred through a study of diabetes patients with gastroparesis who were given Domperidone (10 mg three times daily) or Metoclopramide (10 mg three times daily) for six weeks. The researchers evaluated gastric emptying half-time (T½) as the main outcome, while considering symptoms of nausea, vomiting, and bloating. The study evaluated both negative side effects and participant medication adherence. Results: The gastric emptying reduction using Domperidone exceeded that of Metoclopramide following administration to patients, as Domperidone decreased T½ from 125.6 ± 18.4 minutes to 98.2 ± 15.6 minutes while Metoclopramide decreased T½ from 124.8 ± 17.9 minutes to 107.5 ± 16.9 minutes (p = 0.04). The patients who received Domperidone reported better decreases in nausea, vomiting, and early satiety symptoms than those who received Metoclopramide (p=0.03, p=0.02, and p=0.04). The occurrence of extrapyramidal symptoms together with QT prolongation proved more common in patients treated with Metoclopramide. Compliance was similar between groups. Conclusions: Diabetic patients with gastroparesis experienced superior gastric motility response and symptom relief after taking domperidone compared to metoclopramide, along with better outcomes regarding extrapyramidal symptom development.
References
Caturano A, Cavallo M, Nilo D, Vaudo G, Russo V, Galiero R et al. Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions. Gastrointestinal Disorders. 2024 Feb; 6(1): 214-29. doi: 10.3390/gidisord6010016. DOI: https://doi.org/10.3390/gidisord6010016
Sattaru K, Madhu MT, Singh JK, Kandi V, Gupta A, Ca J et al. A Comprehensive Review of the Effects of Diabetes Mellitus on the Gastrointestinal System. Cureus. 2025 Jan; 17(1). doi: 10.7759/cureus.77845. DOI: https://doi.org/10.7759/cureus.77845
Young CF, Moussa M, Shubrook JH. Diabetic Gastroparesis: A Review. Diabetes Spectrum. 2020 Aug; 33(3): 290-7. doi: 10.2337/ds19-0062. DOI: https://doi.org/10.2337/ds19-0062
Zavaleta MJ, Yovera JG, Marreros DM, Robles LD, Taype KR, Gálvez KN et al. Diabetic Gastroenteropathy: An Underdiagnosed Complication. World Journal of Diabetes. 2021 Jun; 12(6): 794. doi: 10.4239/wjd.v12.i6.794. DOI: https://doi.org/10.4239/wjd.v12.i6.794
Ahmed MS, Forde H, Smith D. Diabetic gastroparesis: Clinical Features, Diagnosis and Management. Irish Journal of Medical Science (1971-). 2023 Aug; 192(4): 1687-94. doi: 10.1007/s11845-022-03191-8. DOI: https://doi.org/10.1007/s11845-022-03191-8
Uppaluri S, Jain MA, Ali H, Shingala J, Amin D, Ajwani T et al. Pathogenesis and Management of Diabetic Gastroparesis: An Updated Clinically Oriented Review. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2024 Mar; 18(3): 102994. doi: 10.1016/j.dsx.2024.102994. DOI: https://doi.org/10.1016/j.dsx.2024.102994
Junqueira DR, Bennett D, Huh SY, Fahrbach K, Neupane B, Betts M. Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-Analysis. Drugs in Research and Development. 2023 Mar; 23(1): 1-20. doi: 10.1007/s40268-023-00413-x. DOI: https://doi.org/10.1007/s40268-023-00413-x
Zheng LF, Liu S, Zhou L, Zhang XL, Yu X, Zhu JX. Dopamine and Gastrointestinal Motility. Dopamine in the Gut. Singapore: Springer Singapore. 2021 Apr: 133-202. doi: 10.1007/978-981-33-6586-5_5. DOI: https://doi.org/10.1007/978-981-33-6586-5_5
Lu X, Liu Q, Deng Y, Wu J, Mu X, Yang X et al. Research Progress on the Roles of Dopamine and Dopamine Receptors in Digestive System Diseases. Journal of Cellular and Molecular Medicine. 2024 Apr; 28(7): e18154. doi: 10.1111/jcmm.18154. DOI: https://doi.org/10.1111/jcmm.18154
Yu L, Shao R, Guo Q, Hong H, Zhu N. The Methodology for Preparing Domperidone: Strategies, Routes and Reaction Processes. Royal Society of Chemistry Advances. 2022;12(35): 22869-80. doi: 10.1039/D2RA03777G. DOI: https://doi.org/10.1039/D2RA03777G
Bonetto S, Gruden G, Beccuti G, Ferro A, Saracco GM, Pellicano R. Management of Dyspepsia and Gastroparesis in Patients with Diabetes. A Clinical Point of View in the Year 2021. Journal of Clinical Medicine. 2021 Mar; 10(6): 1313. doi: 10.3390/jcm10061313. DOI: https://doi.org/10.3390/jcm10061313
Sanger GJ and Andrews PL. An Analysis of the Pharmacological Rationale for Selecting Drugs to Inhibit Vomiting or Increase Gastric Emptying During Treatment of Gastroparesis. Alimentary Pharmacology and Therapeutics. 2023 May; 57(9): 962-78. doi: 10.1111/apt.17466. DOI: https://doi.org/10.1111/apt.17466
Dimino J and Kuo B. Current Concepts in Gastroparesis and Gastric Neuromuscular Disorders—Pathophysiology, Diagnosis, and Management. Diagnostics. 2025 Apr; 15(7): 935. doi: 10.3390/diagnostics15070935. DOI: https://doi.org/10.3390/diagnostics15070935
Galura G, Bravenec C, Myneedu K, Hejazi R, Sarosiek I, Deoker A et al. S0473 Domperidone Is Superior Compared with Metoclopramide in Improving Gastroparesis Symptoms: A Systematic Review and Meta-Analysis. Official journal of the American College of Gastroenterology. 2020 Oct; 115: S237-8. doi: 10.14309/01.ajg.0000703940.85438.74. DOI: https://doi.org/10.14309/01.ajg.0000703940.85438.74
Ibrahim FA, Farhat AN, Butt NA, Sadiq MA, Rafiq AB, MD C. Ondansetron vs Domperidone in the Treatment of Vomiting in Children with Acute Diarrhea: A Randomized, Double-Blind Study. Pakistan Journal of Medical Health Sciences. 2022; 16: 944-7. doi: 10.53350/pjmhs22161944. DOI: https://doi.org/10.53350/pjmhs22161944
Puoti MG, Assa A, Benninga M, Broekaert IJ, Carpi FJ, Deganello Saccomani M et al. Drugs in Focus: Domperidone. Journal of Pediatric Gastroenterology and Nutrition. 2023 Aug; 77(2): e13-22. doi: 10.1097/MPG.0000000000003822. DOI: https://doi.org/10.1097/MPG.0000000000003822
Cheng Y, Chen C, Yang H, Fu M, Zhong X, Wang B et al. Association Between Domperidone Administered Via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance. Journal of Personalized Medicine. 2021 Aug; 11(9): 846. doi: 10.3390/jpm11090846. DOI: https://doi.org/10.3390/jpm11090846
Kalas MA, Trivedi B, Kalas M, Chavez LO, McCallum RW. Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile. Gastrointestinal Disorders. 2023 Aug; 5(3): 317-28. doi: 10.3390/gidisord5030026. DOI: https://doi.org/10.3390/gidisord5030026
Alkhowaiter S, Al Rasheed MM, Alammar N, Alotaibi A, Altuwaijri M, Alshankiti S et al. Safety of Prolonged Use of Metoclopramide and Domperidone as Treatment for Chronic Gastrointestinal Dysmotility Disorders in Patients with Systemic Sclerosis. Saudi Pharmaceutical Journal. 2024 May; 32(5): 102039. doi: 10.1016/j.jsps.2024.102039. DOI: https://doi.org/10.1016/j.jsps.2024.102039
Zheng T and Camilleri M. Management of Gastroparesis. Gastroenterology and Hepatology. 2021 Nov; 17(11): 515.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
